Australian medical device company Sirtex Medical Limited (ASX: SRX) announced today that its board of directors has recommended acceptance of a A$1.87 billion (US$1.4 billion) acquisition proposal by Chinese alternative asset fund manager CDH Investments.
Yaoshibang, a Guangzhou-based online pharmacy trading and education platform, announced that it has completed a RMB420 million (US$65.7 million) series C round led by Shunwei Capital and DCM Ventures.
Chinese used car e-commerce platform Uxin has set terms for its US$437 million initial public offering on NASDAQ, according to its security filing.
Chinese electric vehicle manufacturer Future Mobility Corporation, the parent company of Byton, has placed an order for a paint shop capable of dealing with 150,000 cars per year in Nanjing, according to an announcement by German mechanical and plant engineering firm Dürr.
China’s largest retailer Alibaba Group Holding has joined SoftBank to invest 15 billion India rupee (US$222 million) in Indian e-commerce platform Paytm Mall, as part of the 30 billion India rupee funding commitment initially announced in April, according to Indian local media reports.
Japanese automaker Toyota Motor Corporation has announced a US$1 billion investment in Grab Holdings Inc., a Singapore-based ride hailing company backed by China’s largest ride hailing firm Didi Chuxing.
Shanghai-based pharmaceutical and medical device firm WuXi AppTec has led a strategic funding round in Insilico Medicine, a Baltimore-based artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research.
WuXi Biologics (2269.HK), an open-access biologics technology company based in China, is to invest US$60 million and hire approximately 150 employees to establish a biologics clinical and commercial manufacturing facility in Worcester, Massachusetts in the United States. The facility will be WuXi Biologics’ 11th global drug substance manufacturing facility, the firm said today in an announcement.
Alibaba’s fintech affiliate Ant Financial has made a strategic investment in Xingbianli, a checkout-free convenience store operator that focuses on placing snack bars in offices. The size of the investment in Sequoia-backed Xingbianli was not disclosed.
Health Mall, a Guangzhou-based online sports equipment and services platform has raised a RMB500 million (US$78 million) series C round, the firm announced at a press conference in Guangzhou.
Chinese used car auction platform Tiantianpaiche has received US$100 million strategic investment Autohome, a Chinese automobile online platform, according to Tiantianpaiche’s announcement on its official WeChat account.
Beijing and Hong Kong-based investment firm Hillhouse Capital has led a US$35 million series B+ round in antibody and recombinant protein biotherapeutics firm Hangzhou Just Biotherapeutics (HJB).
Chinese private equity fund Green Harbor Investment has led a RMB800 million (US$125 million) series D round in Nanjing-based customer-to-business used car auction platform Chezhibao.
China’s Zhejiang Silk Road Fund has participated in a US$100 million series B round in CMR Surgical Ltd, a British company developing surgical robots.
China’s largest retailer Alibaba Group Holding Ltd has made a strategic investment to acquire 10% stake in Chinese pregnancy and parenting online portal and e-commerce platform Babytree Inc., valuing the later at RMB14 billion (US$2.19 billion), according to Chinese media reports citing insiders.
Alibaba’s financial services unit Ant Financial has invested RMB2.06 billion (US$321 million) in bike sharing firm Hellobike, valuing the latter at US$1.47 billion and giving birth to a new unicorn company in China, according to Shanghai-listed Yonou Bike’s security filing.
Finally, one Chinese electric vehicle company has reached the critical moment of delivering its vehicles to face the real-life tests and inspections by consumers. NIO, a Shanghai-based EV unicorn with a reported valuation of between US$3 billion to US$5 billion, delivered its first batch of NIO ES8, a seven-seater electric SUV, today in Shanghai, NIO announced today.
Chinese e-commerce giant Alibaba Group Holding Ltd. wants to invest over RMB100 billion (US$15.6 billion) on smart logistics to improve delivery reach and efficiency, the company’s founder and executive chairman Jack Ma said this morning at a conference in Hangzhou.
In a move that further threatens Chinese e-commerce giant Alibaba Group Holding’s dominance in omni-channel retail, Chinese conglomerate Dalian Wanda Group will join tech giant Tencent Holdings Ltd. to set up an Internet technology firm to strengthen its position in retail, according to Wanda’s announcement.
To further its global expansion to rival Uber, China’s largest ride-hailing operator Didi Chuxing has participated in a US$175 million round in Estonian ride-hailing start-up Taxify, valuing the company at US$1 billion.
Alibaba Group Holding Limited (NYSE: BABA) and its logistic arm Cainiao Network have led a strategic investment of US$1.38 billion in Chinese express delivery company ZTO Express, in exchange for an approximately 10% stake in the company.
Chinese incubator and venture capital firm Sinovation Ventures has invested RMB37.5 million (US$5.8 million) in return for a 3% stake in a unite of Tencent-backed Chinese fresh produce retailer Yonghui Superstores.
Chinese alternative asset fund manager CDH Investments and Beijing-based Leadyond Capital have led a RMB250 million (US$39 million) series B round in Chengdu-based drug discovery firm HitGen, according to HitGen’s announcement.
Chinese electric vehicle company NIO, backed by Tencent Holdings Ltd., has filed confidentially for a planned U.S. initial public offering, according to media reports citing insiders.
Chinese e-commerce firm JD.com Inc plans to debut a new in-car delivery service in partnership with Chinese electric vehicle company NIO.
Pivotal bioVenture Partners China (Pivotal China), a member of Nan Fung Life Sciences announced the closing of Pivotal bioVenture Partners China USD Fund I, raising US$150 million to incubate and build life sciences companies in China.
China and US-headquartered biomedical firm Brii Bio has raised US$260 million from Sequoia Capital, Yunfeng Capital and others.
China’s largest ride-hailing firm Didi Chuxing has released a safety overhaul after it suspended its Didi Hitch service last week, following the murder of a female passenger that shocked the country.
BMW China Services Ltd. has received two self-driving road test licenses from Shanghai regulators, making it the first foreign automaker to gain such permits, according to the official website of Shanghai Municipal People’s Government.
Chinese investment firm Shenzhen Capital Group Co., Ltd. has partnered with Wu Capital, a Chinese family office, to lead a US$128 million series A round in Roadstar.ai, an artificial intelligence start-up focused on research and development of level 4 autonomous driving technologies.
American electric vehicle maker Tesla Inc. has gained green light from China to set up its 100% owned company in Shanghai.